Neuraxis, INC financial data

Symbol
NRXS on NYSE
Location
11611 N. Meridian St, Suite 330, Carmel, IN
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 147 % +514%
Quick Ratio 2.47 % +224%
Debt-to-equity 235 %
Return On Equity -599 % -207%
Return On Assets -179 % +84.4%
Operating Margin -222 % +42.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 9.86M shares +44.1%
Common Stock, Shares, Outstanding 9.86M shares +44.1%
Entity Public Float 16.4M USD
Common Stock, Value, Issued 9.86K USD +44.1%
Weighted Average Number of Shares Outstanding, Basic 8.52M shares +23.1%
Weighted Average Number of Shares Outstanding, Diluted 8.52M shares +23.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 3.22M USD +41.9%
Research and Development Expense 265K USD +158%
General and Administrative Expense 9.13M USD -11.3%
Operating Income (Loss) -7.13M USD +17.9%
Net Income (Loss) Attributable to Parent -7.17M USD +53%
Earnings Per Share, Basic -1 USD/shares +63.9%
Earnings Per Share, Diluted -1 USD/shares +63.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.99M USD +239%
Accounts Receivable, after Allowance for Credit Loss, Current 129K USD -12.7%
Inventory, Net 131K USD +208%
Assets, Current 6.62M USD +213%
Property, Plant and Equipment, Net 101K USD +5.87%
Operating Lease, Right-of-Use Asset 257K USD -20.7%
Assets 7.09M USD +169%
Accounts Payable, Current 465K USD -58.5%
Accrued Liabilities, Current 1.65M USD +26.1%
Liabilities, Current 2.35M USD -69.1%
Operating Lease, Liability, Noncurrent 220K USD -26.2%
Other Liabilities, Noncurrent 268K USD
Liabilities 2.83M USD -64.1%
Retained Earnings (Accumulated Deficit) -60.8M USD -13.4%
Stockholders' Equity Attributable to Parent 4.25M USD
Liabilities and Equity 7.09M USD +169%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.6M USD -20.4%
Net Cash Provided by (Used in) Financing Activities -69.8K USD -105%
Net Cash Provided by (Used in) Investing Activities -7.29K USD +16.1%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 9.86M shares +44.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.69M USD -53092%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.24K USD -86.8%
Deferred Tax Assets, Valuation Allowance 10.2M USD +18.5%
Deferred Tax Assets, Gross 10.5M USD +20.2%
Operating Lease, Liability 289K USD -16.5%
Payments to Acquire Property, Plant, and Equipment 18K USD +22.3%
Lessee, Operating Lease, Liability, to be Paid 375K USD -22.1%
Property, Plant and Equipment, Gross 485K USD +5.39%
Operating Lease, Liability, Current 69.2K USD +43.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 87.9K USD -23.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 97.5K USD -12.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.15 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 85.5K USD -36.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 82.5K USD -4.97%
Deferred Tax Assets, Operating Loss Carryforwards 8.02M USD +22%
Preferred Stock, Shares Issued 3.9M shares
Preferred Stock, Shares Authorized 1.12M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 89.6K USD +0.63%
Additional Paid in Capital 65M USD +34.5%
Preferred Stock, Shares Outstanding 3.9M shares
Depreciation, Depletion and Amortization 6.36K USD -40.8%
Deferred Tax Assets, Net of Valuation Allowance 238K USD +229%
Share-based Payment Arrangement, Expense 0 USD
Interest Expense -89.3K USD -139%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%